Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Becton Dickinson, Corning; Empire Genomics; Emergent Technologies; Octa Phillip Bioscience Managers

NEW YORK (GenomeWeb News) – Becton Dickinson this week completed the sale of its Discovery Labware business to Corning for approximately $720 million in cash. The sale excludes BD's Advanced Bioprocessing platform.

Empire Genomics has opened a new clinical lab facility at its headquarters on the Buffalo Niagara Medical Campus in upstate New York and expects to create more than 50 new jobs within the next five years. The firm also introduced this week its multiple myeloma test for aiding physicians in therapeutic guidance.

Emergent Technologies said this week that it has launched a life sciences business incubator in Austin, Texas, to help entrepreneurs and early-stage firms. The incubator will provide lab and office space, conference and meeting facilities, tech support, and access to advisors for business planning and strategy, research, IP and licensing, and partnering initiatives.

Octa Phillip Bioscience Managers announced a first close on its second fund, the Asia Pacific Healthcare Fund II, intended to support the healthcare and life sciences sector in Australia. Thus far, the fund has attracted A$55 million (US$57 million) from Australian institutions IOOF and MIESF. Octa Phillip said that the fund will remain open for investment for 12 months from this first close.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.